HECTD1
Basic information
Region (hg38): 14:31100117-31207804
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the HECTD1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 11 | |||||
missense | 70 | 73 | ||||
nonsense | 2 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 2 | 2 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 73 | 4 | 10 |
Variants in HECTD1
This is a list of pathogenic ClinVar variants found in the HECTD1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
14-31100976-T-G | not specified | Uncertain significance (Jan 11, 2023) | ||
14-31100992-C-G | not specified | Uncertain significance (Jun 13, 2022) | ||
14-31101060-G-C | not specified | Uncertain significance (Nov 11, 2024) | ||
14-31101195-G-A | Benign (Dec 31, 2019) | |||
14-31102945-A-G | Likely benign (Apr 01, 2023) | |||
14-31103045-G-A | Benign (Apr 10, 2018) | |||
14-31105465-C-T | not specified | Uncertain significance (Dec 04, 2024) | ||
14-31105593-A-C | not specified | Uncertain significance (Jun 22, 2023) | ||
14-31105603-C-T | not specified | Uncertain significance (Aug 10, 2021) | ||
14-31105650-G-T | Uncertain significance (Feb 09, 2023) | |||
14-31106812-G-A | not specified | Uncertain significance (May 18, 2023) | ||
14-31107009-T-C | not specified | Uncertain significance (Nov 14, 2023) | ||
14-31107011-A-C | not specified | Uncertain significance (May 26, 2024) | ||
14-31107027-T-C | not specified | Uncertain significance (Jan 26, 2022) | ||
14-31107052-T-C | not specified | Uncertain significance (Nov 10, 2022) | ||
14-31107163-C-T | not specified | Uncertain significance (Jun 16, 2024) | ||
14-31107170-A-C | not specified | Uncertain significance (Dec 03, 2024) | ||
14-31107196-G-C | not specified | Uncertain significance (Dec 06, 2022) | ||
14-31107203-T-C | Likely benign (May 22, 2018) | |||
14-31107208-T-G | Likely benign (Sep 01, 2024) | |||
14-31109432-T-G | not specified | Uncertain significance (Sep 29, 2022) | ||
14-31109575-C-T | not specified | Uncertain significance (Dec 19, 2023) | ||
14-31113186-C-T | not specified | Uncertain significance (Jul 05, 2023) | ||
14-31113320-T-C | Benign (Jan 27, 2022) | |||
14-31113328-G-A | not specified | Uncertain significance (Oct 04, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
HECTD1 | protein_coding | protein_coding | ENST00000399332 | 42 | 107693 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 5.69e-13 | 124764 | 0 | 28 | 124792 | 0.000112 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 5.01 | 869 | 1.40e+3 | 0.623 | 0.0000750 | 16996 |
Missense in Polyphen | 289 | 611.9 | 0.4723 | 7339 | ||
Synonymous | 0.992 | 454 | 482 | 0.943 | 0.0000243 | 5113 |
Loss of Function | 9.81 | 14 | 139 | 0.101 | 0.00000837 | 1621 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000287 | 0.000287 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000223 | 0.000223 |
Finnish | 0.0000928 | 0.0000928 |
European (Non-Finnish) | 0.000133 | 0.000132 |
Middle Eastern | 0.000223 | 0.000223 |
South Asian | 0.0000654 | 0.0000654 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: E3 ubiquitin-protein ligase which accepts ubiquitin from an E2 ubiquitin-conjugating enzyme in the form of a thioester and then directly transfers the ubiquitin to targeted substrates. Mediates 'Lys-63'-linked polyubiquitination of HSP90AA1 which leads to its intracellular localization and reduced secretion. Negatively regulating HSP90AA1 secretion in cranial mesenchyme cells may impair their emigration and may be essential for the correct development of the cranial neural folds and neural tube closure. {ECO:0000250|UniProtKB:Q69ZR2}.;
- Pathway
- Immune System;Adaptive Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
(Consensus)
Recessive Scores
- pRec
- 0.104
Intolerance Scores
- loftool
- 0.365
- rvis_EVS
- -2.23
- rvis_percentile_EVS
- 1.33
Haploinsufficiency Scores
- pHI
- 0.712
- hipred
- Y
- hipred_score
- 0.563
- ghis
- 0.643
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.985
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Hectd1
- Phenotype
- growth/size/body region phenotype; craniofacial phenotype; skeleton phenotype; embryo phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); vision/eye phenotype;
Gene ontology
- Biological process
- protein K63-linked ubiquitination
- Cellular component
- Molecular function
- ubiquitin-protein transferase activity;protein binding;metal ion binding